专题：Potassium and Related Disorders

This cluster of papers focuses on the management of hyperkalemia, particularly in patients with kidney diseases. It covers various aspects such as the use of renin-angiotensin-aldosterone system inhibitors, potassium homeostasis, and the effectiveness of treatments like sodium zirconium cyclosilicate and patiromer. Additionally, it explores the association of hyperkalemia with conditions like chronic kidney disease, heart failure, and gastrointestinal adverse events.
最新文献
Discrepancies Between Point of Care and Central Laboratory Sodium and Potassium Measurements in ICU: Analytical Biases and Physician Awareness

article Full Text OpenAlex

Correspondence on “Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach” by Protzenko et al

article Full Text OpenAlex

GLP-1 receptor agonist-associated eosinophilic duodenitis presenting as a bowel obstruction : a case report and literature review

article Full Text OpenAlex

Pneumatosis intestinalis in a patient treated with a glucagon-like peptide-1 receptor agonist and prednisone

article Full Text OpenAlex

A Randomized Trial of Targeted Hyponatremia Correction in Hospitalized Patients

article Full Text OpenAlex

An uncommon culprit: PPI-induced acute tubulointerstitial nephritis in a teenager

article Full Text OpenAlex

Serum magnesium and outcomes in patients with heart failure and reduced ejection fraction: insights from the GALACTIC-HF trial

article Full Text OpenAlex

Lithium toxicity following a change from semaglutide to tirzepatide for weight loss management

article Full Text OpenAlex

Severe Acidemia Without Bicarbonate: Increased Organ Support and Post-ICU Mortality During a Drug Shortage

article Full Text OpenAlex

Zinc supplement: A rare cause of toxic epidermal necrolysis in a pediatric patient

article Full Text OpenAlex

近5年高被引文献
SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

review Full Text OpenAlex 840 FWCI130.2082

2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure

article Full Text OpenAlex 377 FWCI58.7699

Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial

article Full Text OpenAlex 273 FWCI41.371

Heart Failure Drug Treatment—Inertia, Titration, and Discontinuation

article Full Text OpenAlex 258 FWCI33.4845

AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review

review Full Text OpenAlex 255 FWCI39.1856

Diagnosis and Management of Hyponatremia

review Full Text OpenAlex 253 FWCI36.1734

Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases

review Full Text OpenAlex 252 FWCI32.9296

Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions

review Full Text OpenAlex 247 FWCI55.2173

Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials

article Full Text OpenAlex 242 FWCI34.8158

An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors

review Full Text OpenAlex 223 FWCI29.9994